In addition, reduced filamin A levels corrected aberrant Tau levels in cells cultured from PSP patients, while transgenic mice carrying human filamin A recapitulated Tau pathology in neurons [35]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.